Wilmar M. Wiersinga

University of Amsterdam — Netherlands

Medicine · Health Sciences

91h-index33.4kcitations445works8.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Disorders and Treatments(222), Ophthalmology and Eye Disorders(151), Pituitary Gland Disorders and Treatments(99), Growth Hormone and Insulin-like Growth Factors(72), Thyroid Cancer Diagnosis and Treatment(60)

Publications442 total

Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management
The Lancet Diabetes & Endocrinology·2025· 24 cited
Hypothyroxinaemia during gestation is associated with low ferritin and increased levels of inflammatory markers
European Thyroid Journal·2024Open Access
Hyperthyroid Disorders
Research at the University of Copenhagen (University of Copenhagen)·2024
Should hypothyroxinaemia during early gestation be regarded as a condition of oxidative stress?
Endocrine Abstracts·2023
Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis
The Lancet Diabetes & Endocrinology·2023· 203 cited
Transcriptome mapping related genes encoding PR1 protein involved in necrotic symptoms to soybean mosaic virus infection.
PubMed·2023· 29 citedOpen Access
Etiology and Pathogenesis of Graves’ Orbitopathy
2023Open Access
Medical Management of Graves’ Orbitopathy
2023· 1 citedOpen Access
Worldwide Consensus on Thyroid Eye Disease? What Is In a Name?
Thyroid·2022· 2 cited
Hypothyroid Symptoms Throughout Pregnancy Are Predominantly Associated with Thyroxine and Not with Thyrotropin Concentrations
Thyroid·2022· 4 cited
Management of Thyrotoxicosis Without Hyperthyroidism
2022
Graves’ Orbitopathy and Dermopathy
2022
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
Endocrinology and Metabolism·2021· 20 citedOpen Access
The 2021 European Group on Graves’ orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves’ orbitopathy
European Journal of Endocrinology·2021· 896 citedOpen Access
<b><i>European Thyroid Journal:</i></b> Looking Backwards and Forwards
European Thyroid Journal·2021Open Access
Antithyroid drugs in Graves’ hyperthyroidism: differences between “block and replace” and “titration” regimes in frequency of euthyroidism and Graves’ orbitopathy during treatment
Journal of Endocrinological Investigation·2020· 15 citedOpen Access
Asymmetry indicates more severe and active disease in Graves’ orbitopathy: results from a prospective cross-sectional multicentre study
Journal of Endocrinological Investigation·2020· 34 citedOpen Access
Proposal for Standardization of Primary and Secondary Outcomes in Patients with Active, Moderate-to-Severe Graves’ Orbitopathy
European Thyroid Journal·2020· 46 citedOpen Access
Maternal cognitive function during pregnancy in relation to hypo‐ and hyperthyroxinemia
Clinical Endocrinology·2019· 11 citedOpen Access
T4 + T3 combination therapy: any progress?
Endocrine·2019· 34 citedOpen Access
page 1 of 23Next →

Frequent Co-authors

Maarten P. Mourits(14), Mark F. Prummel(14), Luigi Bartalena(9), Kostas Boboridis(9), George J. Kahaly(9), Claudio Marcocci(8), L. Baldeschi(8), Lelio Baldeschi(7), Anja Eckstein(7), Mario Salvi(7), Nicola Currò(7), Marco Nardi(7), Petros Perros(6), Michele Marinò(6), Antonella Boschi(6), Jacques Orgiazzi(6), Leo Koornneef(5), John H. Lazarus(5), Matthias Stahl(5), Arie Berghout(5)